Birth Control Pills Containing Drospirenone: Label Change-Products May Be Associated With a Higher Risk for Blood Clots

Silver Spring, Maryland–(ENWESPF)–April 10, 2012.  

ISSUE: FDA has completed its review of recent observational (epidemiologic) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.Based on this review, FDA has concluded that drospirenone-containing birth control pills may be associated with a higher risk for blood clots than other progestin-containing pills.

BACKGROUND: Drospirenone is a synthetic version of the female hormone, progesterone, also referred to as a progestin. FDA is adding…